Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
Advanced Oxygen Therapy Inc. (AOTI)
3512, Seagate Way, STE 100,
92056
Oceanside, CA
USA
USA
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
This company is co-exhibitor of
Enterprise Florida Inc.
Location
Hall map
Fairground map
Our range of products
Product categories
- 05 Disposables and consumables
- 05.15 Wound care equipment
- 05.15.12 Other wound care equipment
Other wound care equipment
Our products
Product category: Other wound care equipment
Single-use Sacral Systems
AOTI offers a single-use Topical Wound Oxygen (TWO2)Sacral system utilizing targeted therapy for all types of wounds on the torso, such as pressure ulcers, and can easily be applied at any care site, including hospitals, LTACs, Wound Care Clinics, SNFs, nursing homes, and to the patients’ homes
These single-use devices are easy to set-up and operate, and can be disposed of between treatments, eliminating any need for cleaning between patients
The Sacral system is comprised of a transparent, inflatable adhesive patch, associated tubing, foam belt, and pressure-regulating valve
Indications
These single-use devices are easy to set-up and operate, and can be disposed of between treatments, eliminating any need for cleaning between patients
The Sacral system is comprised of a transparent, inflatable adhesive patch, associated tubing, foam belt, and pressure-regulating valve
Indications
- TWO2 therapy has been shown to be particularly effective as an adjunctive treatment modality for closing chronic wounds, that include venous, diabetic, and pressure ulcers
- TWO2 therapy has also been shown to be effective in treating diseased wounds, post-surgical infections, amputations, infected residual limbs, frostbite, and burns
- TWO2 therapy allows for targeted treatments utilizing oxygen pressure applied directly to the wound site, resulting in none of the potential negative systemic effects seen in other therapies
- The ability to close previously non-responsive and slow-to-heal wounds provides significant clinical, quality of life, and cost saving benefits
Product category: Other wound care equipment
Single-use Extremity Systems
AOTI offers a wide range of single-use Topical Wound Oxygen (TWO2) extremity chambers to allow our therapy to be applied effortlessly while meeting the needs of our customers in such varied care sites as hospitals, LTACs, Wound Care Clinics, SNFs, nursing homes, and patient homes
Our single-use devices are easy to set-up and operate, and can be disposed of between treatments, eliminating any need for cleaning between patients
The fundamentals of operation for our TWO2 therapy devices are the same. The extremity system is comprised of an inflatable plastic chamber and an electro-mechanical therapy controller unit
Indications
Our single-use devices are easy to set-up and operate, and can be disposed of between treatments, eliminating any need for cleaning between patients
The fundamentals of operation for our TWO2 therapy devices are the same. The extremity system is comprised of an inflatable plastic chamber and an electro-mechanical therapy controller unit
Indications
- TWO2 therapy has been shown to be particularly effective as an adjunctive treatment modality for closing chronic wounds, that include venous, diabetic, and pressure ulcers
- TWO2 therapy has also been shown to be effective in treating diseased wounds, post-surgical infections, amputations, infected residual limbs, frostbite, and burns
- TWO2 therapy allows for targeted treatments utilizing oxygen pressure applied directly to the wound site, resulting in none of the potential negative systemic effects seen in other therapies
- The ability to close previously non-responsive and slow-to-heal wounds provides significant clinical, quality of life, and cost saving benefits
About us
Company portrait
AOTI is dedicated to providing Advanced Wound Care products that utilize our patented non-invasive Topical Wound Oxygen (TWO2) therapy
Our innovative products can help close all wound types, and are particularly effective in chronic (diabetic, pressure, and venous ulcers) and acute (post-surgical, cosmetic, and burn) wounds
TWO2 therapy is unique in that it helps to address the fundamental reasons chronic wounds fail to heal by; reversing wound tissue hypoxia, stimulating the underlying cellular mechanisms needed for tissue regeneration, creating non-contact sequential compression to reduce edema and promote perfusion, and creating an environment that destroys unwanted pathogens and combats infection
In closing previously unresponsive wounds, TWO2 therapy has significant impact on saving limbs, reducing overall healthcare costs, and greatly improving patients’ quality of life
The Global Chronic Wound Epidemic
Worldwide expenditures related to treating chronic wounds are estimated to be in excess of $55 Billion annually, making it one of the most costly components of the health care system
Chronic ulcers afflict 33 million people globally and nine million people in the USA, with growing prevalence due to increasing diabetes and obesity rates, as well as a growing aging population
It is estimated that 25 percent of older adults will suffer from chronic limb ulceration by 2050
Our innovative products can help close all wound types, and are particularly effective in chronic (diabetic, pressure, and venous ulcers) and acute (post-surgical, cosmetic, and burn) wounds
TWO2 therapy is unique in that it helps to address the fundamental reasons chronic wounds fail to heal by; reversing wound tissue hypoxia, stimulating the underlying cellular mechanisms needed for tissue regeneration, creating non-contact sequential compression to reduce edema and promote perfusion, and creating an environment that destroys unwanted pathogens and combats infection
In closing previously unresponsive wounds, TWO2 therapy has significant impact on saving limbs, reducing overall healthcare costs, and greatly improving patients’ quality of life
The Global Chronic Wound Epidemic
Worldwide expenditures related to treating chronic wounds are estimated to be in excess of $55 Billion annually, making it one of the most costly components of the health care system
Chronic ulcers afflict 33 million people globally and nine million people in the USA, with growing prevalence due to increasing diabetes and obesity rates, as well as a growing aging population
It is estimated that 25 percent of older adults will suffer from chronic limb ulceration by 2050